Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

Cancer Cell

Volumn 15, Issue 1, 2009, Pages 35-44

  Erler, Janine T ^a,b   Bennewith, Kevin L ^a,c   Cox, Thomas R ^b   Lang, Georgina ^b   Bird, Demelza ^b   Koong, Albert ^a   Le, Quynh Thu ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

CELLCYCLE

Indexed keywords

3 AMINOPROPIONITRILE; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; PROTEIN LYSINE 6 OXIDASE; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER INVASION; CANCER RESEARCH; CANCER SURVIVAL; CELL ADHESION; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 57849100048     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.11.012     Document Type: Article

References (40)

1. Ahn G.O., and Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13 (2008) 193-205
2. Cairns R.A., Khokha R., and Hill R.P. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr. Mol. Med. 3 (2003) 659-671
3. Cameron J.D., Skubitz A.P., and Furcht L.T. Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2766-2773
4. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., and Post M. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J. Clin. Invest. 105 (2000) 577-587
5. Condeelis J., and Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266
6. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
7. Denholm E.M., Wolber F.M., and Phan S.H. Secretion of monocyte chemotactic activity by alveolar macrophages. Am. J. Pathol. 135 (1989) 571-580
8. Denko N.C., Fontana L.A., Hudson K.M., Sutphin P.D., Raychaudhuri S., Altman R., and Giaccia A.J. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 (2003) 5907-5914
9. Du R., Lu K.V., Petritsch C., Liu P., Ganss R., Passegue E., Song H., Vandenberg S., Johnson R.S., Werb Z., and Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13 (2008) 206-220
10. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
11. Erler J.T., Bennewith K.L., Nicolau M., Dornhofer N., Kong C., Le Q.T., Chi J.T., Jeffrey S.S., and Giaccia A.J. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440 (2006) 1222-1226
12. Fogelgren B., Polgar N., Szauter K.M., Ujfaludi Z., Laczko R., Fong K.S., and Csiszar K. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J. Biol. Chem. 280 (2005) 24690-24697
13. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
14. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., and Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25 (2004) 1543-1549
15. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
16. Harrison C.A., Gossiel F., Layton C.M., Bullock A.J., Johnson T., Blumsohn A., and MacNeil S. Use of an in vitro model of tissue-engineered skin to investigate the mechanism of skin graft contraction. Tissue Eng. 12 (2006) 3119-3133
17. Hiratsuka S., Watanabe A., Aburatani H., and Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8 (2006) 1369-1375
18. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93 (2001) 266-276
19. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
20. Kagan H.M., and Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88 (2003) 660-672
21. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
22. Kent M.J., Light N.D., and Bailey A.J. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem. J. 225 (1985) 745-752
23. Kirschmann D.A., Seftor E.A., Fong S.F., Nieva D.R., Sullivan C.M., Edwards E.M., Sommer P., Csiszar K., and Hendrix M.J. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62 (2002) 4478-4483
24. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkila P., Kantor C., Gahmberg C.G., Salo T., Konttinen Y.T., et al. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17 (1999) 768-774
25. Kusmartsev S., Eruslanov E., Kubler H., Tseng T., Sakai Y., Su Z., Kaliberov S., Heiser A., Rosser C., Dahm P., et al. Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. J. Immunol. 181 (2008) 346-353
26. Lazarus H.M., Cruikshank W.W., Narasimhan N., Kagan H.M., and Center D.M. Induction of human monocyte motility by lysyl oxidase. Matrix Biol. 14 (1995) 727-731
27. Liu C., Yu S., Kappes J., Wang J., Grizzle W.E., Zinn K.R., and Zhang H.G. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109 (2007) 4336-4342
28. Maki J.M., Rasanen J., Tikkanen H., Sormunen R., Makikallio K., Kivirikko K.I., and Soininen R. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106 (2002) 2503-2509
29. Palamakumbura A.H., and Trackman P.C. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal. Biochem. 300 (2002) 245-251
30. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 (2005) 241-254
31. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
32. Serafini P., Borrello I., and Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16 (2006) 53-65
33. Shahan T.A., Fawzi A., Bellon G., Monboisse J.C., and Kefalides N.A. Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J. Biol. Chem. 275 (2000) 4796-4802
34. Shojaei F., and Ferrara N. Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells. Cancer Res. 68 (2008) 5501-5504
35. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12 (2006) 895-904
36. Van Rooijen N., and Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174 (1994) 83-93
37. van Rooijen N., and van Kesteren-Hendrikx E. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol. 373 (2003) 3-16
38. Yang L., DeBusk L.M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., Matrisian L.M., Carbone D.P., and Lin P.C. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6 (2004) 409-421
39. Yang L., Huang J., Ren X., Gorska A.E., Chytil A., Aakre M., Carbone D.P., Matrisian L.M., Richmond A., Lin P.C., and Moses H.L. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13 (2008) 23-35
40. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., and Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95 (2006) 272-281